Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Douglas Micalizzi is a medical oncologist at Massachusetts General Hospital specializing in breast cancer, early cancer detection and hereditary cancer risk. He is also the Clinical Director of the Cancer Early Detection and Diagnostics Clinic. Dr. Micalizzi received his undergraduate degree in chemistry from Villanova University. He pursued his MD from University of Colorado and PhD in molecular biology at the University of Colorado in the lab of Dr. Heide Ford.

The Importance of Testing 2023
Oncologists and patient advocates discuss the importance of early detection and treatment across cancer types, including skin, lung, and breast.
Author
Doug Micalizzi, MD, PhD - Guest Faculty
Image
The Importance of Early Detection 2023

Drs. Meredith McKean, Dr. Doug Micalizzi and patient advocate and lung cancer survivor, Ivy Elkins, discuss the importance of early detection and treatment across cancer types, including skin, lung, and breast.

To watch the complete playlist click here.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora